373 related articles for article (PubMed ID: 28011098)
1. Serum IGF-I, IGFBP-3 and ALS concentrations and physical performance in young swimmers during a training season.
Tourinho Filho H; Pires M; Puggina EF; Papoti M; Barbieri R; Martinelli CE
Growth Horm IGF Res; 2017 Feb; 32():49-54. PubMed ID: 28011098
[TBL] [Abstract][Full Text] [Related]
2. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
[TBL] [Abstract][Full Text] [Related]
3. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
7. IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes.
Eklund E; Hellberg A; Berglund B; Brismar K; Hirschberg AL
Front Endocrinol (Lausanne); 2021; 12():708421. PubMed ID: 34484121
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training.
Koziris LP; Hickson RC; Chatterton RT; Groseth RT; Christie JM; Goldflies DG; Unterman TG
J Appl Physiol (1985); 1999 Apr; 86(4):1436-42. PubMed ID: 10194233
[TBL] [Abstract][Full Text] [Related]
9. Serum IGF-I concentrations are low in female bodybuilders in the pre-contest phase.
Monteiro DPPF; Correa M; Neto TT; Martinelli CE; Filho HT
Growth Horm IGF Res; 2021; 60-61():101420. PubMed ID: 34364063
[TBL] [Abstract][Full Text] [Related]
10. Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men.
Grandys M; Majerczak J; Kuczek P; Sztefko K; Duda K; Zoladz JA
Growth Horm IGF Res; 2017 Feb; 32():41-48. PubMed ID: 28017505
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency.
Ertl DA; Chen J; Gleiss A; Janu D; Sagmeister S; Raimann A; Riedl S; Haeusler G
Horm Res Paediatr; 2020; 93(6):371-379. PubMed ID: 33341813
[TBL] [Abstract][Full Text] [Related]
12. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
13. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
Völkl TM; Rauh M; Schöfl C; Dörr HG
Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
15. Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit.
Hwang DL; Lee PD; Cohen P
Growth Horm IGF Res; 2008 Feb; 18(1):65-74. PubMed ID: 17719253
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes.
Karila T; Koistinen H; Seppälä M; Koistinen R; Seppälä T
Clin Endocrinol (Oxf); 1998 Oct; 49(4):459-63. PubMed ID: 9876343
[TBL] [Abstract][Full Text] [Related]
17. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
18. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
20. IGF-I, IGFBP-3 and ALS generation test in Turner syndrome.
Pessoa de Queiroz AN; Collett-Solberg PF; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
Growth Horm IGF Res; 2007 Jun; 17(3):254-60. PubMed ID: 17540594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
